A Pilot Multi-arm Study of sEphB4-HSA in Combination With Different Chemotherapy Regimens in Patients With Specific Advanced or Metastatic Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 22 Jul 2017
At a glance
- Drugs SEphB4-HSA (Primary) ; Cisplatin; Docetaxel; Gemcitabine; Paclitaxel
- Indications Adenocarcinoma; Gallbladder cancer; Head and neck cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Therapeutic Use
- 15 Jul 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 15 Jul 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 08 Sep 2015 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2017 as per ClinicalTrials.gov record.